Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by The Fifth People's Hospital of Suzhou.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
The Fifth People's Hospital of Suzhou
ClinicalTrials.gov Identifier:
NCT01380951
First received: June 23, 2011
Last updated: NA
Last verified: June 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)